fda news tirzepatide declares shortage over for popular weight-loss, diabetes drug The @U.S. Food and Drug
Description
After two months, there was decrease in weight by 12 kg, body fat percent by 15%, visceral fat by 7%, and a reduction in insulin dose, glycemic variability, and HbA1c
- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake
Book a consultation
Its USDA Certified organic, non-GMO, gluten-free, alcohol-free, and paleo-friendly
